Solbec Pharmaceuticals

Government 20 Dec 2007

Solbec Pharmaceuticals chairman steps down

Solbec Pharmaceuticals Ltd's Anthony Kiernan has announced his retirement as chairman and director of the company.

Financial Services 16 Oct 2007

Solbec's Coramsine wins tick from one US doctor

Osborne Park-based Solbec Pharmaceuticals Ltd has had a small win, with the United States Food and Drug Administration allowing the use of its Coramsine cancer treatment under a Physician's Investigational New Drug application.

13 Jan 2006

Solbec shares up on US patent

Shares in Fremantle company Solbec Pharmaceuticals Ltd have soared on news it has been awarded a US patent it considers a strong indicator of further IP portfolio growth.

27 Nov 2005

Solbec seeks to clean up option overhang

Perth biotechology firm Solbec Pharmaceuticals Ltd is seeking to remove a big "overhang" of options, offering holders of the instruments shares in the company to reduce the almost 150 million options on issue.

13 Nov 2005

Solbec anti-cancer compound gets good news from FDA

Solbec Pharmaceuticals Limited has announced its lead anti-cancer compound Coramsine has received orphan drug designation from the US Food and Drug Administration.

23 Aug 2005

Solbec Pharmaceuticals

Solbec Pharmaceuticals 15-Aug-05 Has been granted a US Patent Pending for "Rhamnose Binding Protein".

15 Feb 2005

Solbec psoriasis trial complete

SOLBEC Pharmaceuticals has announced that its safety trial of Coamsine in the treatment of psoriasis has finished successfully and ahead of schedule.

23 Nov 2004

Solbec success in mice mesothelioma

A treatment developed by Western Australian biotechnology company Solbec Pharmaceuticals has led to total remission of mesothelioma in mice.

14 Sep 2004

Solbec patients want another dose

SOME patients taking part in phase 1 trials of Solbec Pharmaceuticals anti-cancer drug SBP002 have asked to continue taking the drug.

10 Aug 2004

Solbec’s boosted

Solbec Pharmaceuticals has received a positive international preliminary examination report on its manufacturing patent application for the method of separation of the key ingredi

25 Nov 2003

Local weed drug goes into trials

A MINER turned biotechnical player making an anti-cancer drug from a declared weed is three months away from getting the first results from clinical trials relating to its cancer dr

30 Sep 2003

Solbec Pharmaceuticals Ltd - 23-Sep-03

Solbec Pharmaceuticals Ltd - 23-Sep-03 Has agreed to sell its interest in the Lawley Pharmaceuticals Joint Venture to Michael Buckley for $850,000.

23 Sep 2003

Solbec bales on Lawley project

SOLBEC Pharmaceuticals has agreed to sell its interest in the Lawley Pharmaceuticals Joint Venture, following a comprehensive review of the hormone replacement therapy project.

25 Mar 2003

Decrease of Substantial or relevant interests

Solbec Pharmaceuticals Ltd 13/3/03

04 Mar 2003

Devil's apple drug under further investigation

Solbec Pharmaceuticals is continuing its investigation into the behaviour of its lead cancer product, developed from elements found in weed colloquially known as ‘Devil's Apple'.

12 Mar 2002

Weeding out cancer scourge

BEHIND the locked doors of an industrial unit in Osborne Park, Solbec Pharmaceuticals is working on a drug it hopes could cure the scourge of cancer.

Solbec Pharmaceuticals

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark